echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > "Voriconazole" of Puli pharmaceutical will be listed in Holland and Germany soon, and it will be available in China

    "Voriconazole" of Puli pharmaceutical will be listed in Holland and Germany soon, and it will be available in China

    • Last Update: 2019-02-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Today, Puli pharmaceutical announced that its company's voriconazole for injection has entered the category to be reviewed preferentially At the same time, the company recently received a notice of technical review from the Netherlands drug evaluation committee (CBG) approving voriconazole for injection (200mg) The technical review of the product has ended on February 7, 2019 The conclusion is approval The main country of review is the Netherlands and the participating country is Germany The following is the original announcement:
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.